a-paraddise.cebio.org a-paraddise.cebio.org

a-paraddise.cebio.org

Welcome! | a-paraddise.cebio.org

Epigenetic drug discovery for NTDs 2016 - Click Here. We will employ a target-based strategy for the development of novel drug leads against epigenetic targets in schistosomiasis, leishmaniasis, Chagas disease and malariafocusing on key histone modifying enzymes (HME), in particular those involved in acetylation/deacetylation and methylation/demethylation. The project will build on the proven methodologydeveloped in the SEtTReND FP7 project (2010-2012). HDAC inhibitors have been tested against parasites,...

http://a-paraddise.cebio.org/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR A-PARADDISE.CEBIO.ORG

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

September

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.6 out of 5 with 13 reviews
5 star
4
4 star
4
3 star
3
2 star
0
1 star
2

Hey there! Start your review of a-paraddise.cebio.org

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

2.7 seconds

CONTACTS AT A-PARADDISE.CEBIO.ORG

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Welcome! | a-paraddise.cebio.org | a-paraddise.cebio.org Reviews
<META>
DESCRIPTION
Epigenetic drug discovery for NTDs 2016 - Click Here. We will employ a target-based strategy for the development of novel drug leads against epigenetic targets in schistosomiasis, leishmaniasis, Chagas disease and malariafocusing on key histone modifying enzymes (HME), in particular those involved in acetylation/deacetylation and methylation/demethylation. The project will build on the proven methodologydeveloped in the SEtTReND FP7 project (2010-2012). HDAC inhibitors have been tested against parasites,...
<META>
KEYWORDS
1 objectives
2 workpackages
3 participants
4 publications
5 useful links
6 workshop
7 to register
8 schistosoma mansoni
9 plasmodium falciparum
10 leishmania
CONTENT
Page content here
KEYWORDS ON
PAGE
objectives,workpackages,participants,publications,useful links,workshop,to register,schistosoma mansoni,plasmodium falciparum,leishmania,user login,username *,password *,request new password
SERVER
Apache/2.2.3 (CentOS)
POWERED BY
PHP/5.2.16
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Welcome! | a-paraddise.cebio.org | a-paraddise.cebio.org Reviews

https://a-paraddise.cebio.org

Epigenetic drug discovery for NTDs 2016 - Click Here. We will employ a target-based strategy for the development of novel drug leads against epigenetic targets in schistosomiasis, leishmaniasis, Chagas disease and malariafocusing on key histone modifying enzymes (HME), in particular those involved in acetylation/deacetylation and methylation/demethylation. The project will build on the proven methodologydeveloped in the SEtTReND FP7 project (2010-2012). HDAC inhibitors have been tested against parasites,...

INTERNAL PAGES

a-paraddise.cebio.org a-paraddise.cebio.org
1

Publications | a-paraddise.cebio.org

http://a-paraddise.cebio.org/content/publications

Vitor Coutinho Carneiro - Epigenetic Changes Modulate Schistosome Egg. Guilherme Oliveira - Cancer and parasitic infections. Schistosomiasis: Setting Routes for Drug Discovery. Raymond Pierce - Anti-Parasitic Drug Discovery.

2

Objectives | a-paraddise.cebio.org

http://a-paraddise.cebio.org/content/objectives

The principal objectives of the project are:. The identification of HMEs from. And the molecular characterization and functional characterization of selected potential targets. In the case of. A gene knockout strategy will be used to validate HMEs as therapeutic targets. Leishmania, T. cruzi, S. mansoni. Using HME class inhibitors and inhibitors developed specifically against. Leishmania, S. mansoni, P. falciparum. Optimisation of inhibitor structures by chemical synthesis based on molecular modelling st...

3

About | a-paraddise.cebio.org

http://a-paraddise.cebio.org/content/about

Anti-Parasitic Drug Discovery in Epigenetics. Type of funding scheme. Work programme topics addressed. HEALTH.2013.2.3.4-2: Drug development for neglected parasitic diseases. Name of coordinating person. Raymond J. Pierce. CIIL – Centre d’Infection et d’Immunité de Lille. Institut Pasteur de Lille. 1 rue du Prof. A. Calmette. 59019 – Lille.

4

User account | a-paraddise.cebio.org

http://a-paraddise.cebio.org/user/password

Username or e-mail address: *.

5

Workpackages | a-paraddise.cebio.org

http://a-paraddise.cebio.org/content/workpackages

The proposed work plan leverages strategies, methodologies and experience gained during the previous project and exploits the available pool of HME inhibitors in an integrated approach. We will carry out phenotypic screens of. With these inhibitors, as well as performing high throughput and structure based screens on recombinant HMEs from these parasites. Moreover, inhibitors developed notably against. Will enable the bioinformatics platform (7a) to identify all the HMEs of interest for the project. ...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL PAGES IN THIS WEBSITE

7

LINKS TO THIS WEBSITE

pc.pharmazie.uni-halle.de pc.pharmazie.uni-halle.de

Medicinal Chemistry

http://pc.pharmazie.uni-halle.de/medchem

Martin Luther University Halle-Wittenberg. Wechseln zur deutschen Sprachversion. To the beginning of the text (Jump over the navigation). Faculty I of Natural Science - Biological Science. Pharmaceutical Chemistry and Clinical Pharmacy. Head of the group. New book on "Epigenetic Targets in Drug Discovery" available. AG Sippl December 2015. AG Sippl December 2015. Novel epigenetic inhibitors for the treatment of schistosomiasis. In this way, we consider that we have laid the foundations for the developmen...

adlego.se adlego.se

AParaDDisE – Anti-Parasitic Drug Discovery in Epigenetics | Adlego

http://www.adlego.se/383/aparaddise-anti-parasitic-drug-discovery-in-epigenetics

AParaDDisE – Anti-Parasitic Drug Discovery in Epigenetics. Jan 16, 2014. Combination therapy of tumors. Kanceras HDAC6-projekt tilldelas anslag från Vinnova. The true value of a good partnership! Adlego is testing OsteoDex in an in-vivo model of breast cancer! Drugs for treatment of colorectal cancer, identified with use of three-dimensional cell culture-based screening, was validated in-vivo by Adlego! Adlego is testing OsteoDex in an in-vivo model of breast cancer! Phone: 46 (0)733 42 17 37.

epichembio.eu epichembio.eu

Workshop in Rome: Epigenetic drug discovery for Neglected Parasitic Diseases | Epichembio

http://epichembio.eu/workshop-in-rome-epigenetic-drug-discovery-for-neglected-parasitic-diseases

Workshop in Rome: Epigenetic drug discovery for Neglected Parasitic Diseases Epichembio. 34 986 812 316. WG1 Epigenetic Chemical Probes. Past Activities of Epichembio. Workshop in Rome: Epigenetic drug discovery for Neglected Parasitic Diseases. November 7, 2016. Will take place in Rome on November 30 December 1 2016. Hotel Massimo D’Azeglio. Closeby Termini station). It is organized by the EU-funded A-ParaDDisE project. Candidates registering on the website: http:/ truta.cebio.org/a-workshop. Vigo Unive...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

3

OTHER SITES

a-parada-anteriores.blogspot.com a-parada-anteriores.blogspot.com

jornal a parada: edições anteriores

Se a idéia de utopia está aderida à existência mesma das vanguardas, ainda há futuro para a vanguarda? Como falar de poesia com o fim da utopia? CAETANO, Ana et al. In.: Cacograma, 2001). Poeta e um dos editores do folheto Barkaça, surgido em Divinópolis. É nesse primeiro verão poesia que chega a oitava edição de a parada. sem negar os impiedosos dias de calor da estação, este número mantém o frescor graças às diversas e valiosas participações. Carlos Careqa, Marcelo Coelho, Paulo Leão e Xico Sá. O leito...

a-parada-entrevista.blogspot.com a-parada-entrevista.blogspot.com

jornal a parada: entrevistas

Em julho de 2009, o A Parada conversou com diOli, poeta e um dos editores do folheto literário Barkaça, surgido em Divinópolis. Nesta entrevista, ele fala sobre as estratégias para manter uma publicação independente e também sobre sua produção autoral em poesia. Com uma grande dose de inteligência, irreverência e disposição, a barkaça de diOli, Lopes e Mingau é bastante promissora: se você não conhece, vai conhecer. A entrevista foi parcialmente publicada no A Parada 9. Leia a íntegra aqui. O poeta argen...

a-parada-imprensa.blogspot.com a-parada-imprensa.blogspot.com

jornal a parada: imprensa

Lançamento do número 6. Matéria de Alécio Cunha para o jornal Hoje em Dia sobre o lançamento do sexto número de A Parada, em julho de 2008, no espaço Letras e Ponto. Clique na imagem para ampliar. Salto para o Futuro. Na série Poesia e Escola, de outubro de 2007, o programa Salto para o Futuro (TVE) apresenta o grupo A Parada. Com a mão na mídia. Clique nas imagens para ampliar. Cadernos Temáticos do MEC. Publicada em fevereiro de 2006, nos Cadernos Temáticos do MEC (edição Linguagens), a matéria fala so...

a-parada-videos.blogspot.com a-parada-videos.blogspot.com

a-parada-videos

Modelo Simple. Tecnologia do Blogger.

a-parada.blogspot.com a-parada.blogspot.com

jornal a parada

Acima, A Parada n. 9. O A Parada foi um jornal de literatura e poesia editado em Belo Horizonte, constituído por poemas, contos, entrevistas e trabalhos visuais. A publicação surgiu em 2004 e foi patrocinada pelo CEFET-MG até 2006, período em que foram lançados quatro números. Realizando edições diversas, mas, ao mesmo tempo, buscando manter uma linha editorial coerente, o A Parada publicou tanto autores estreantes como aqueles já inseridos, de alguma forma, na cena cultural de Belo Horizonte.

a-paraddise.cebio.org a-paraddise.cebio.org

Welcome! | a-paraddise.cebio.org

Epigenetic drug discovery for NTDs 2016 - Click Here. We will employ a target-based strategy for the development of novel drug leads against epigenetic targets in schistosomiasis, leishmaniasis, Chagas disease and malariafocusing on key histone modifying enzymes (HME), in particular those involved in acetylation/deacetylation and methylation/demethylation. The project will build on the proven methodologydeveloped in the SEtTReND FP7 project (2010-2012). HDAC inhibitors have been tested against parasites,...

a-parade.deviantart.com a-parade.deviantart.com

A-Parade (Aylin) - DeviantArt

Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 5 Months. This deviant's full pageview. Last Visit: 16 hours ago. This is the place where you can personalize your profile! This ga...

a-paradela.blogspot.com a-paradela.blogspot.com

Águias de Paradela

Ocorreu um erro neste dispositivo. Terça-feira, 31 de julho de 2012. Enviar a mensagem por e-mail. Dê a sua opinião! Publicada por Águias de Paradela. Classificação da 22ª Jornada 2011-2012 - Após desi. Classificação da 22ª Jornada 2011-2012. Resultados da 22ª Jornada 2011-2012. Classificação da 21ª Jornada 2011-2012. Resultados da 21ª Jornada 2011-2012. Número total de visualizações de página. Ver o meu perfil completo. Modelo Picture Window. Imagens de modelos por francisblack.

a-paradigm-shift.biz a-paradigm-shift.biz

Félicitations ! Votre domaine a bien été créé chez OVH !

Votre domaine a-paradigm-shift.biz. A bien été créé chez OVH. Accédez à votre Webmail OVH. Depuis votre Espace Client Web. Consultez la liste des. Vous pouvez dès à présent lui associer un hébergement,. En choisissant la solution la plus adaptée à vos besoins :. Pour héberger vos projets Web :. Site Internet, boutique en ligne,. Alliez la flexibilité du Cloud. À la liberté du dédié. Avec nos solutions VPS clef en main. Accompagnez vos projets Web. Vers une nouvelle étape. Hébergez vos sites Web.

a-paradigm-shift.com a-paradigm-shift.com

Félicitations ! Votre domaine a bien été créé chez OVH !

Votre domaine a-paradigm-shift.com. A bien été créé chez OVH. Accédez à votre Webmail OVH. Depuis votre Espace Client Web. Consultez la liste des. Vous pouvez dès à présent lui associer un hébergement,. En choisissant la solution la plus adaptée à vos besoins :. Pour héberger vos projets Web :. Site Internet, boutique en ligne,. Alliez la flexibilité du Cloud. À la liberté du dédié. Avec nos solutions VPS clef en main. Accompagnez vos projets Web. Vers une nouvelle étape. Hébergez vos sites Web.

a-paradigm-shift.info a-paradigm-shift.info

Félicitations ! Votre domaine a bien été créé chez OVH !

Votre domaine a-paradigm-shift.info. A bien été créé chez OVH. Accédez à votre Webmail OVH. Depuis votre Espace Client Web. Consultez la liste des. Vous pouvez dès à présent lui associer un hébergement,. En choisissant la solution la plus adaptée à vos besoins :. Pour héberger vos projets Web :. Site Internet, boutique en ligne,. Alliez la flexibilité du Cloud. À la liberté du dédié. Avec nos solutions VPS clef en main. Accompagnez vos projets Web. Vers une nouvelle étape. Hébergez vos sites Web.